Browsing by Author Kefford, Richard F.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
2016Evaluation of immune-related response criteria and RECIST v1.1 in patients with advanced melanoma treated with PembrolizumabHersey, Peter; Daud, Adil; et al, Various; Hamid, Omid; Hodi, F. Stephen; Hwu, Wen-Jen; Kefford, Richard F.; Patnaik, Amita; Ribas, Antoni; Robert, Caroline; Weber, Jeffrey; Northern Clinical School: SurgeryEvaluation of immune-related response criteria and RECIST v1.1 in patients with advanced melanoma treated with Pembrolizumab, Journal of Clinical Oncology, vol.34, 13, 2016,pp 1510-1517
2017Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patientsCarlino, Matteo; Long, Georgina; Menzies, Alexander Maxwel; Scolyer, Richard; Ahn, Seong Beom; Breen, Edmond; Kefford, Richard F.; Khan, Alamgir; Lee, Jenny H.; Lim, Su Yin; Rizos, Helen; Welsh, Sarah; Westmead Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Central Clinical School: PathologyEvaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patients, Biomarker Research, vol.5, N/A, 2017,pp 1-12
2016Residual FDG-PET metabolic activity in metastatic melanoma patients with prolonged response to anti-PD-1 therapyCarlino, Matteo; Guminski, Alexander; Kong, Benjamin; Long, Georgina; Menzies, Alexander Maxwel; Kefford, Richard F.; Liniker, Elizabeth; Ramanujam, Sangeetha; Saunders, Catherine A B; Western Clinical School: Medicine (Westmead); Medicine Faculty Office; Central Clinical School: Office; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: MedicineResidual FDG-PET metabolic activity in metastatic melanoma patients with prolonged response to anti-PD-1 therapy, Pigment Cell & Melanoma Research, vol.29, 5, 2016,pp 572-577
2016Residual FDG-PET metabolic activity in metastatic melanoma patients with prolonged response to anti-PD-1 therapyCarlino, Matteo; Guminski, Alexander; Kong, Benjamin; Long, Georgina; Menzies, Alexander Maxwel; Kefford, Richard F.; Liniker, Elizabeth; Ramanujam, Sangeetha; Saunders, Catherine A B; Western Clinical School: Medicine (Westmead); Medicine Faculty Office; Central Clinical School: Office; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: MedicineResidual FDG-PET metabolic activity in metastatic melanoma patients with prolonged response to anti-PD-1 therapy, Pigment Cell & Melanoma Research, vol.29, 5, 2016,pp 572-577